• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022

    6/3/22 10:08:02 AM ET
    $ADPT
    $AGLE
    $ALLO
    $AON
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADPT alert in real time by email

     

    Upgrades

    • Keefe, Bruyette & Woods upgraded the previous rating for Regions Financial Corp (NYSE:RF) from Underperform to Market Perform. For the first quarter, Regions Financial had an EPS of $0.55, compared to year-ago quarter EPS of $0.63. The current stock performance of Regions Financial shows a 52-week-high of $25.57 and a 52-week-low of $18.02. Moreover, at the end of the last trading period, the closing price was at $21.89.
    • Goldman Sachs upgraded the previous rating for Voya Financial Inc (NYSE:VOYA) from Neutral to Buy. Voya Financial earned $1.47 in the first quarter, compared to $1.03 in the year-ago quarter. The stock has a 52-week-high of $74.97 and a 52-week-low of $58.97. At the end of the last trading period, Voya Financial closed at $67.82.
    • According to B. Riley Securities, the prior rating for Ciena Corp (NYSE:CIEN) was changed from Neutral to Buy. For the second quarter, Ciena had an EPS of $0.50, compared to year-ago quarter EPS of $0.62. The stock has a 52-week-high of $78.28 and a 52-week-low of $46.60. At the end of the last trading period, Ciena closed at $50.68.
    • For Cornerstone Building Brands Inc (NYSE:CNR), CIBC upgraded the previous rating of Neutral to Outperformer. Cornerstone Building earned $0.66 in the first quarter, compared to $0.03 in the year-ago quarter. The stock has a 52-week-high of $24.61 and a 52-week-low of $13.51. At the end of the last trading period, Cornerstone Building closed at $24.53.
    • For Ecolab Inc (NYSE:ECL), Credit Suisse upgraded the previous rating of Neutral to Outperform. Ecolab earned $0.82 in the first quarter, compared to $0.81 in the year-ago quarter. The current stock performance of Ecolab shows a 52-week-high of $238.93 and a 52-week-low of $154.31. Moreover, at the end of the last trading period, the closing price was at $173.13.
    • Goldman Sachs upgraded the previous rating for Portland General Electric Co (NYSE:POR) from Neutral to Buy. In the first quarter, Portland Gen Electric showed an EPS of $0.67, compared to $1.07 from the year-ago quarter. At the moment, the stock has a 52-week-high of $57.03 and a 52-week-low of $45.40. Portland Gen Electric closed at $49.35 at the end of the last trading period.
    • According to JP Morgan, the prior rating for Martin Marietta Materials Inc (NYSE:MLM) was changed from Neutral to Overweight. Martin Marietta Materials earned $0.39 in the first quarter, compared to $1.04 in the year-ago quarter. The stock has a 52-week-high of $446.46 and a 52-week-low of $316.73. At the end of the last trading period, Martin Marietta Materials closed at $347.33.

    See all analyst ratings upgrades.

     

    Downgrades

    • For Huntington Bancshares Inc (NASDAQ:HBAN), Keefe, Bruyette & Woods downgraded the previous rating of Market Perform to Underperform. In the first quarter, Huntington Bancshares showed an EPS of $0.32, compared to $0.48 from the year-ago quarter. The stock has a 52-week-high of $17.79 and a 52-week-low of $12.55. At the end of the last trading period, Huntington Bancshares closed at $13.80.
    • For Marsh & McLennan Companies Inc (NYSE:MMC), Morgan Stanley downgraded the previous rating of Equal-Weight to Underweight. In the first quarter, Marsh & McLennan showed an EPS of $2.30, compared to $1.99 from the year-ago quarter. The stock has a 52-week-high of $183.14 and a 52-week-low of $133.86. At the end of the last trading period, Marsh & McLennan closed at $160.09.
    • According to Morgan Stanley, the prior rating for Aon PLC (NYSE:AON) was changed from Equal-Weight to Underweight. For the first quarter, Aon had an EPS of $4.83, compared to year-ago quarter EPS of $4.28. The current stock performance of Aon shows a 52-week-high of $341.98 and a 52-week-low of $223.19. Moreover, at the end of the last trading period, the closing price was at $278.63.
    • According to B of A Securities, the prior rating for JOANN Inc (NASDAQ:JOAN) was changed from Buy to Neutral. JOANN earned $0.22 in the first quarter, compared to $0.46 in the year-ago quarter. The current stock performance of JOANN shows a 52-week-high of $17.50 and a 52-week-low of $7.00. Moreover, at the end of the last trading period, the closing price was at $7.90.
    • For Westlake Corp (NYSE:WLK), JP Morgan downgraded the previous rating of Overweight to Neutral. In the first quarter, Westlake showed an EPS of $5.83, compared to $1.87 from the year-ago quarter. The current stock performance of Westlake shows a 52-week-high of $141.19 and a 52-week-low of $78.06. Moreover, at the end of the last trading period, the closing price was at $133.38.
    • According to Barclays, the prior rating for Moody's Corporation (NYSE:MCO) was changed from Overweight to Equal-Weight. Moody's earned $2.89 in the first quarter, compared to $4.06 in the year-ago quarter. The stock has a 52-week-high of $407.94 and a 52-week-low of $269.47. At the end of the last trading period, Moody's closed at $293.57.
    • Goldman Sachs downgraded the previous rating for The Travelers Companies Inc (NYSE:TRV) from Neutral to Sell. In the first quarter, Travelers Companies showed an EPS of $4.22, compared to $2.73 from the year-ago quarter. The current stock performance of Travelers Companies shows a 52-week-high of $187.98 and a 52-week-low of $144.44. Moreover, at the end of the last trading period, the closing price was at $178.06.
    • CIBC downgraded the previous rating for The Lion Electric Co (NYSE:LEV) from Outperformer to Neutral. For the first quarter, Lion Electric had an EPS of $0.01, compared to year-ago quarter EPS of $0.15. The stock has a 52-week-high of $23.45 and a 52-week-low of $4.73. At the end of the last trading period, Lion Electric closed at $5.63.
    • Piper Sandler downgraded the previous rating for Micron Technology Inc (NASDAQ:MU) from Neutral to Underweight. For the second quarter, Micron Technology had an EPS of $2.14, compared to year-ago quarter EPS of $0.98. The current stock performance of Micron Technology shows a 52-week-high of $98.45 and a 52-week-low of $65.67. Moreover, at the end of the last trading period, the closing price was at $75.37.
    • For Aeglea BioTherapeutics Inc (NASDAQ:AGLE), Needham downgraded the previous rating of Buy to Hold. In the first quarter, Aeglea BioTherapeutics showed an EPS of $0.37, compared to $0.28 from the year-ago quarter. The current stock performance of Aeglea BioTherapeutics shows a 52-week-high of $8.50 and a 52-week-low of $0.71. Moreover, at the end of the last trading period, the closing price was at $0.73.

    See all analyst ratings downgrades.

     

    Initiations

    • With a Neutral rating, Piper Sandler initiated coverage on Adaptive Biotechnologies Corp (NASDAQ:ADPT). The price target seems to have been set at $7.50 for Adaptive Biotechnologies. Adaptive Biotechnologies earned $0.44 in the first quarter, compared to $0.29 in the year-ago quarter. The current stock performance of Adaptive Biotechnologies shows a 52-week-high of $43.40 and a 52-week-low of $6.20. Moreover, at the end of the last trading period, the closing price was at $7.99.
    • Oppenheimer initiated coverage on Starry Group Holdings Inc (NYSE:STRY) with a Perform rating. The price target for Starry Group Holdings is set to $10.00. At the moment, the stock has a 52-week-high of $10.35 and a 52-week-low of $6.14. Starry Group Holdings closed at $10.26 at the end of the last trading period.
    • Roth Capital initiated coverage on Aravive Inc (NASDAQ:ARAV) with a Buy rating. The price target for Aravive is set to $15.00. For the first quarter, Aravive had an EPS of $0.62, compared to year-ago quarter EPS of $0.44. At the moment, the stock has a 52-week-high of $6.94 and a 52-week-low of $1.02. Aravive closed at $1.22 at the end of the last trading period.
    • Roth Capital initiated coverage on Valmont Industries Inc (NYSE:VMI) with a Buy rating. The price target for Valmont Industries is set to $297.00. In the first quarter, Valmont Industries showed an EPS of $3.07, compared to $2.57 from the year-ago quarter. The current stock performance of Valmont Industries shows a 52-week-high of $277.00 and a 52-week-low of $203.31. Moreover, at the end of the last trading period, the closing price was at $259.29.
    • Roth Capital initiated coverage on Lindsay Corp (NYSE:LNN) with a Neutral rating. The price target for Lindsay is set to $135.00. For the second quarter, Lindsay had an EPS of $1.32, compared to year-ago quarter EPS of $1.08. The current stock performance of Lindsay shows a 52-week-high of $179.26 and a 52-week-low of $118.28. Moreover, at the end of the last trading period, the closing price was at $135.03.
    • With an Outperform rating, Northland Capital Markets initiated coverage on Xos Inc (NASDAQ:XOS). The price target seems to have been set at $5.00 for Xos. The stock has a 52-week-high of $9.00 and a 52-week-low of $1.92. At the end of the last trading period, Xos closed at $3.13.
    • Piper Sandler initiated coverage on Invitae Corp (NYSE:NVTA) with an Underweight rating. The price target for Invitae is set to $2.50. For the first quarter, Invitae had an EPS of $0.78, compared to year-ago quarter EPS of $0.63. The stock has a 52-week-high of $35.51 and a 52-week-low of $3.30. At the end of the last trading period, Invitae closed at $3.56.
    • With an Overweight rating, Cantor Fitzgerald initiated coverage on ObsEva SA (NASDAQ:OBSV). The price target seems to have been set at $6.00 for ObsEva. ObsEva earned $0.14 in the first quarter, compared to $0.29 in the year-ago quarter. The current stock performance of ObsEva shows a 52-week-high of $3.58 and a 52-week-low of $1.08. Moreover, at the end of the last trading period, the closing price was at $1.96.
    • With a Buy rating, B of A Securities initiated coverage on CCC Intelligent Solutions Holdings Inc (NYSE:CCCS). The price target seems to have been set at $13.00 for CCC Intelligent Solutions. The current stock performance of CCC Intelligent Solutions shows a 52-week-high of $13.46 and a 52-week-low of $7.41. Moreover, at the end of the last trading period, the closing price was at $9.47.
    • With a Neutral rating, Citigroup initiated coverage on Otonomo Technologies Ltd (NASDAQ:OTMO). The price target seems to have been set at $1.50 for Otonomo Technologies. The stock has a 52-week-high of $9.48 and a 52-week-low of $1.10. At the end of the last trading period, Otonomo Technologies closed at $1.32.
    • Chardan Capital initiated coverage on Cleanspark Inc (NASDAQ:CLSK) with a Buy rating. The price target for Cleanspark is set to $12.00. Cleanspark earned $0.00 in the second quarter, compared to $0.22 in the year-ago quarter. The current stock performance of Cleanspark shows a 52-week-high of $23.60 and a 52-week-low of $4.53. Moreover, at the end of the last trading period, the closing price was at $5.85.
    • With a Buy rating, Chardan Capital initiated coverage on Marathon Digital Holdings Inc (NASDAQ:MARA). The price target seems to have been set at $19.00 for Marathon Digital Holdings. For the first quarter, Marathon Digital Holdings had an EPS of $0.02, compared to year-ago quarter EPS of $0.03. At the moment, the stock has a 52-week-high of $83.45 and a 52-week-low of $8.53. Marathon Digital Holdings closed at $9.34 at the end of the last trading period.
    • Chardan Capital initiated coverage on Eqonex Ltd (NASDAQ:EQOS) with a Neutral rating. The price target for Eqonex is set to $1.25. The current stock performance of Eqonex shows a 52-week-high of $9.67 and a 52-week-low of $1.00. Moreover, at the end of the last trading period, the closing price was at $1.11.
    • Chardan Capital initiated coverage on Core Scientific Inc (NASDAQ:CORZ) with a Buy rating. The price target for Core Scientific is set to $8.00. The stock has a 52-week-high of $11.49 and a 52-week-low of $2.94. At the end of the last trading period, Core Scientific closed at $3.04.
    • Needham initiated coverage on Loyalty Ventures Inc (NASDAQ:LYLT) with a Buy rating. The price target for Loyalty Ventures is set to $16.00. At the moment, the stock has a 52-week-high of $52.50 and a 52-week-low of $9.44. Loyalty Ventures closed at $11.14 at the end of the last trading period.
    • Baird initiated coverage on Fate Therapeutics Inc (NASDAQ:FATE) with a Neutral rating. The price target for Fate Therapeutics is set to $28.00. For the first quarter, Fate Therapeutics had an EPS of $0.68, compared to year-ago quarter EPS of $0.48. The current stock performance of Fate Therapeutics shows a 52-week-high of $97.43 and a 52-week-low of $20.49. Moreover, at the end of the last trading period, the closing price was at $23.36.
    • With a Neutral rating, Baird initiated coverage on Allogene Therapeutics Inc (NASDAQ:ALLO). The price target seems to have been set at $11.00 for Allogene Therapeutics. For the first quarter, Allogene Therapeutics had an EPS of $0.56, compared to year-ago quarter EPS of $0.25. The current stock performance of Allogene Therapeutics shows a 52-week-high of $27.86 and a 52-week-low of $6.42. Moreover, at the end of the last trading period, the closing price was at $7.87.
    • With a Perform rating, Piper Sandler initiated coverage on Starry Group Holdings Inc (NYSE:STRY). The price target seems to have been set at $10.00 for Starry Group Holdings. The stock has a 52-week-high of $10.35 and a 52-week-low of $6.14. At the end of the last trading period, Starry Group Holdings closed at $10.26.
    • With an Overweight rating, Piper Sandler initiated coverage on Guardant Health Inc (NASDAQ:GH). The price target seems to have been set at $65.00 for Guardant Health. In the first quarter, Guardant Health showed an EPS of $0.91, compared to $0.49 from the year-ago quarter. The current stock performance of Guardant Health shows a 52-week-high of $133.82 and a 52-week-low of $27.65. Moreover, at the end of the last trading period, the closing price was at $41.44.
    • Piper Sandler initiated coverage on NeoGenomics Inc (NASDAQ:NEO) with an Overweight rating. The price target for NeoGenomics is set to $13.00. For the first quarter, NeoGenomics had an EPS of $0.20, compared to year-ago quarter EPS of $0.04. The current stock performance of NeoGenomics shows a 52-week-high of $54.74 and a 52-week-low of $7.26. Moreover, at the end of the last trading period, the closing price was at $8.67.
    • Piper Sandler initiated coverage on Exact Sciences Corp (NASDAQ:EXAS) with a Neutral rating. The price target for Exact Sciences is set to $50.00. Exact Sciences earned $1.04 in the first quarter, compared to $0.18 in the year-ago quarter. The stock has a 52-week-high of $133.99 and a 52-week-low of $46.15. At the end of the last trading period, Exact Sciences closed at $51.22.
    • With an Outperform rating, Raymond James initiated coverage on Snowflake Inc (NYSE:SNOW). The price target seems to have been set at $184.00 for Snowflake. In the first quarter, Snowflake showed an EPS of $0.08, compared to $0.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $405.00 and a 52-week-low of $112.10. Snowflake closed at $138.24 at the end of the last trading period.

    See all analyst ratings initiations.

    Get the next $ADPT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADPT
    $AGLE
    $ALLO
    $AON

    CompanyDatePrice TargetRatingAnalyst
    MARA Holdings Inc.
    $MARA
    2/9/2026$8.00Underweight
    Morgan Stanley
    Westlake Corporation
    $WLK
    2/9/2026$88.00Outperform → Neutral
    Mizuho
    Huntington Bancshares Incorporated
    $HBAN
    2/3/2026$21.00Outperform
    Evercore ISI
    Martin Marietta Materials Inc.
    $MLM
    1/28/2026$690.00Buy → Hold
    Loop Capital
    Ecolab Inc.
    $ECL
    1/23/2026Buy → Hold
    Erste Group
    Micron Technology Inc.
    $MU
    1/23/2026$350.00 → $500.00Buy
    HSBC Securities
    Micron Technology Inc.
    $MU
    1/22/2026Outperform
    William Blair
    Regions Financial Corporation
    $RF
    1/20/2026$31.00Outperform → Mkt Perform
    Keefe Bruyette
    More analyst ratings

    $ADPT
    $AGLE
    $ALLO
    $AON
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    July 30, 2024 - FDA Roundup: July 30, 2024

    For Immediate Release: July 30, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA is announcing the fiscal year (FY) 2025 user fee rates for importers approved to participate in the Voluntary Qualified Importer Program (VQIP) and accreditation and certification bodies interested in participating in the Accredited Third-Party C

    7/30/24 3:38:18 PM ET
    $GH
    Medical Specialities
    Health Care

    May 28, 2021 - FDA Approves First Targeted Therapy for Lung Cancer Mutation Previously Considered Resistant to Drug Therapy

    For Immediate Release: May 28, 2021 Today, the U.S. Food and Drug Administration approved Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation called KRAS G12C and who have received at least one prior systemic therapy. This is the first approved targeted therapy for tumors with any KRAS mutation, which accounts for ap

    5/28/21 1:05:48 PM ET
    $AMGN
    $GH
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Medical Specialities

    May 21, 2021 - FDA Approves First Targeted Therapy for Subset of Non-Small Cell Lung Cancer

    For Immediate Release: May 21, 2021 Today, the U.S. Food and Drug Administration approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer whose tumors have specific types of genetic mutations: epidermal growth factor receptor (EGFR) exon 20 insertion mutations. The FDA also approved the Guardant360 CDx (Guardant Health Inc.) as a companion diagnostic for Ry

    5/21/21 12:50:51 PM ET
    $JNJ
    $GH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Specialities

    $ADPT
    $AGLE
    $ALLO
    $AON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Morgan Stanley initiated coverage on MARA Holdings Inc. with a new price target

    Morgan Stanley initiated coverage of MARA Holdings Inc. with a rating of Underweight and set a new price target of $8.00

    2/9/26 7:01:42 AM ET
    $MARA
    EDP Services
    Technology

    Westlake Corporation downgraded by Mizuho with a new price target

    Mizuho downgraded Westlake Corporation from Outperform to Neutral and set a new price target of $88.00

    2/9/26 7:00:44 AM ET
    $WLK
    Major Chemicals
    Industrials

    Evercore ISI resumed coverage on Huntington Banc with a new price target

    Evercore ISI resumed coverage of Huntington Banc with a rating of Outperform and set a new price target of $21.00

    2/3/26 6:55:35 AM ET
    $HBAN
    Major Banks
    Finance

    $ADPT
    $AGLE
    $ALLO
    $AON
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Liu Teyin M bought $7,821,723 worth of shares (23,200 units at $337.14), increasing direct ownership by 856% to 25,910 units (SEC Form 4)

    4 - MICRON TECHNOLOGY INC (0000723125) (Issuer)

    1/15/26 7:07:13 PM ET
    $MU
    Semiconductors
    Technology

    Director Smith Edgar R. Iii bought $1,128,578 worth of shares (208,996 units at $5.40) (SEC Form 4)

    4 - First Guaranty Bancshares, Inc. (0001408534) (Issuer)

    1/2/26 5:04:59 PM ET
    $FGBI
    Savings Institutions
    Finance

    Director Reynolds Marshall T bought $250,004 worth of shares (46,297 units at $5.40), increasing direct ownership by 2% to 1,993,821 units (SEC Form 4)

    4 - First Guaranty Bancshares, Inc. (0001408534) (Issuer)

    1/2/26 5:04:02 PM ET
    $FGBI
    Savings Institutions
    Finance

    $ADPT
    $AGLE
    $ALLO
    $AON
    SEC Filings

    View All

    SEC Form 13F-NT filed by Voya Financial Inc.

    13F-NT - Voya Financial, Inc. (0001535929) (Filer)

    2/12/26 11:46:20 AM ET
    $VOYA
    Life Insurance
    Finance

    SEC Form DEFA14A filed by Ciena Corporation

    DEFA14A - CIENA CORP (0000936395) (Filer)

    2/12/26 11:10:05 AM ET
    $CIEN
    Telecommunications Equipment
    Utilities

    SEC Form DEF 14A filed by Ciena Corporation

    DEF 14A - CIENA CORP (0000936395) (Filer)

    2/12/26 10:56:34 AM ET
    $CIEN
    Telecommunications Equipment
    Utilities

    $ADPT
    $AGLE
    $ALLO
    $AON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    U.S. Figure Skating Elevates Athlete Development and Fan Engagement with Snowflake Intelligence

    The collaboration brings Snowflake Intelligence, an enterprise intelligence agent, to the heart of U.S. Figure Skating, transforming data into faster decisions, smarter strategy and stronger foundation for the sport Snowflake Intelligence will combine athlete performance, fan engagement, and business operations data into a single, reliable source of insight Leaders and coaches will gain contextual visibility into performance trends, using natural language to uncover deeper insights and inform decisions on and off the ice The collaboration builds on Snowflake's commitment as the Official Data Collaboration Provider for Team USA and the LA28 Games to deliver the most data-driven Game

    2/12/26 3:00:00 PM ET
    $SNOW
    Computer Software: Prepackaged Software
    Technology

    Guardant Health Launches Community Colorectal Cancer Screening Grant Program in Recognition of CRC Awareness Month, Applications Now Open

    Patient and Public Health Groups Invited to Apply for Up to 100 Shield Colorectal Cancer Blood Tests to Support Community Screening Events and Educational Outreach in March PALO ALTO, Calif., Feb. 12, 2026 /PRNewswire/ -- Ahead of Colorectal Cancer (CRC) Awareness Month in March, Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced the launch of its Community Colorectal Cancer Screening Grant Program, designed to support community-led efforts to expand access to colorectal cancer screening throughout March. As part of the grant program, Guardant Health will provide selected patient advocacy, non-profit, public health and health-adjacent organizations with

    2/12/26 2:35:00 PM ET
    $GH
    Medical Specialities
    Health Care

    Ciena Announces Internet Availability of 2026 Annual Meeting Proxy Materials

    Ciena® Corporation (NYSE:CIEN), the global leader in high-speed connectivity, announced today that proxy materials are now available for its 2026 Annual Meeting of Stockholders to be held Thursday, March 26, 2026 at 3:00 p.m. Eastern Time. Event: 2026 Annual Meeting of Stockholders Date: Thursday, March 26, 2026, 3:00 p.m. ET Listen Live: An audio webcast of the meeting, accompanied by a slide presentation, will be posted at the time of the event. Stockholders of record will be able to ask questions through the virtual platform. Registration and all materials can be found at www.virtualshareholdermeeting.com/CIEN2026 Stockholder Materials: Proxy materials for the 2026 Annual Meeting

    2/12/26 11:00:00 AM ET
    $CIEN
    Telecommunications Equipment
    Utilities

    $ADPT
    $AGLE
    $ALLO
    $AON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bailey Carolyn covered exercise/tax liability with 760 shares and exercised 2,000 shares at a strike of $16.43, increasing direct ownership by 15% to 9,716 units (SEC Form 4)

    4 - Third Coast Bancshares, Inc. (0001781730) (Issuer)

    2/11/26 5:49:46 PM ET
    $TCBX
    Banks
    Finance

    New insider Greenleaf Clint Tuxberry claimed ownership of 19,803 shares (SEC Form 3)

    3 - Third Coast Bancshares, Inc. (0001781730) (Issuer)

    2/11/26 5:49:18 PM ET
    $TCBX
    Banks
    Finance

    Officer Peacock Christopher Seay covered exercise/tax liability with 75 shares, decreasing direct ownership by 5% to 1,552 units (SEC Form 4)

    4 - Third Coast Bancshares, Inc. (0001781730) (Issuer)

    2/11/26 5:48:56 PM ET
    $TCBX
    Banks
    Finance

    $ADPT
    $AGLE
    $ALLO
    $AON
    Leadership Updates

    Live Leadership Updates

    View All

    Aon Appoints Joe Peiser as CEO of Risk Capital

    DUBLIN, Feb. 12, 2026 /PRNewswire/ -- Aon plc (NYSE:AON), a leading global professional services firm, today announced the appointment of Joe Peiser as CEO of Risk Capital.  In this role, Peiser will lead Aon's Risk Capital capabilities across Commercial Risk and Reinsurance Solutions. Peiser will continue to report to Andy Marcell, CEO of Global Solutions for Aon. A search for the role of CEO of Commercial Risk is underway. Peiser's appointment reflects Aon's broader strategy to strengthen how the firm helps clients navigate increasing volatility by connecting risk with the most efficient forms of capital. Peiser's enhanced leadership role will accelerate Aon's work to deliver solutions tha

    2/12/26 8:00:00 AM ET
    $AON
    Specialty Insurers
    Finance

    Core Natural Resources Reports Fourth Quarter 2025 Results

    Resumes longwall mining at Leer South, enters 2026 operating at targeted production ratesCompletes transition to new seam at West Elk, enters 2026 operating at targeted production ratesGenerates net cash provided by operating activities of $107.3 million and free cash flow1 of $27.0 millionSignificantly increases contracted position in all segments, at prices projected to drive advantageous margins Returns $26.8 million to stockholders, bringing the total returned to stockholders in 2025 to $245.1 million CANONSBURG, Pa., Feb. 12, 2026 /PRNewswire/ -- Today, Core Natural Resources, Inc. (NYSE:CNR) ("Core" or the "company") reported a net loss of $79.0 million, or ($1.54) per diluted share, i

    2/12/26 6:55:00 AM ET
    $CNR
    Coal Mining
    Energy

    Martin Marietta Appoints George F. Schoen as Executive Vice President, General Counsel and Corporate Secretary

    RALEIGH, N.C., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Martin Marietta Materials, Inc. (NYSE:MLM) (Martin Marietta or the Company), a leading national supplier of aggregates and heavy building materials, today announced the appointment of George F. Schoen as Executive Vice President, General Counsel and Corporate Secretary, further strengthening the Company's leadership team as it executes its long-term strategic plan. Mr. Schoen will join the Company in March 2026. Mr. Schoen, who most recently served as Co-Chair of the Global Mergers and Acquisitions Practice at Cravath, Swaine & Moore LLP, is widely recognized as one of the nation's foremost M&A and corporate governance attorneys. He has adv

    2/11/26 4:15:00 PM ET
    $MLM
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    $ADPT
    $AGLE
    $ALLO
    $AON
    Financials

    Live finance-specific insights

    View All

    Martin Marietta Reports Fourth-Quarter and Full-Year 2025 Results

    Achieved Fourth-Quarter and Full-Year Records for Aggregates Revenues, Gross Profit and Margin Double-Digit Improvement in Full-Year Aggregates Unit Profitability Specialties Business Delivers Record Fourth-Quarter and Full-Year Revenues and Gross Profit Company Provides 2026 Guidance RALEIGH, N.C., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Martin Marietta Materials, Inc. (NYSE:MLM) ("Martin Marietta" or the "Company"), a leading national supplier of aggregates and heavy building materials, today reported results for the fourth quarter and year ended December 31, 2025. Fourth-Quarter and Full-Year Highlights(Financial highlights are for continuing operations, unless otherwise noted)  Quarter

    2/11/26 6:55:00 AM ET
    $MLM
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    Westlake Announces Fourth Quarter and Full Year Earnings for 2025 Conference Call

    Westlake Corporation (NYSE:WLK) will release its fourth quarter and full year 2025 earnings prior to the market opening on Tuesday, February 24, 2026. The company will host a conference call at 11:00 a.m. Eastern Time (10:00 a.m. Central Time) on the same day to discuss the earnings release. To access the conference by phone, it is necessary to pre-register at https://register-conf.media-server.com/register/BI0ebecf9ae9804486aff77f70a8cc367f. Once registered, you will receive a phone number and unique PIN number. When you dial in, you will input the PIN number to be placed into the call. The conference call and replay will be available via webcast at https://edge.media-server.com/mmc/p/

    2/10/26 9:00:00 AM ET
    $WLK
    Major Chemicals
    Industrials

    CleanSpark Delivers $181 Million in Q1 Revenue, Strengthens Balance Sheet, and Advances Multi-Gigawatt AI Infrastructure Platform

    Secures up to 890 MW of New Utility-Grade Power Capacity and Expands AI-Ready Site Portfolio Across Texas and Georgia LAS VEGAS, Feb. 5, 2026 /PRNewswire/ -- CleanSpark, Inc. (NASDAQ:CLSK) ("CleanSpark" or the "Company"), today reported financial results for the quarter ended December 31, 2025. "CleanSpark exited the quarter with one of the strongest balance sheets in our sector and a power and land portfolio that is increasingly scarce," said Matt Schultz, CleanSpark's CEO and Chairman. "We strengthened our financial foundation, secured up to 890 megawatts of high-quality uti

    2/5/26 4:05:00 PM ET
    $CLSK
    Finance: Consumer Services
    Finance

    $ADPT
    $AGLE
    $ALLO
    $AON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Xos Inc.

    SC 13D/A - Xos, Inc. (0001819493) (Subject)

    12/9/24 3:57:56 PM ET
    $XOS
    Auto Parts:O.E.M.
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Xos Inc.

    SC 13D/A - Xos, Inc. (0001819493) (Subject)

    12/9/24 3:45:37 PM ET
    $XOS
    Auto Parts:O.E.M.
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Third Coast Bancshares Inc.

    SC 13D/A - Third Coast Bancshares, Inc. (0001781730) (Subject)

    11/20/24 8:16:18 PM ET
    $TCBX
    Banks
    Finance